Article info

Original research
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma

Authors

  1. Correspondence to Dr Andrew S Brohl; Andrew.Brohl{at}moffitt.org
View Full Text

Citation

Ramadoss T, Nichols M, Palacios C, et al
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma

Publication history

  • Accepted August 23, 2024
  • First published September 5, 2024.
Online issue publication 
September 05, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.